LIHIT LAB., INC. AI Stock Analysis
Want to see JP:7975 full AI Analyst Report?
LIHIT LAB., INC. (7975) AI Stock Analysis
LIHIT LAB., INC.
(TSE/TYO:7975)
LIHIT LAB. is pressured by a confluence of fundamental and technical risks. The primary headwinds are a stretched valuation, severely deteriorating cash flows, and a confirmed bearish trend across all moving averages. The company's sole major strength is a rock-solid, debt-free balance sheet, which is currently overshadowed by poor operational execution and declining year-over-year profitability.
LIHIT LAB., INC. (7975) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 3.93B
- Dividend Yield
- 2.15%
- Average Volume (3M)
- 2,243
- Price to Earnings (P/E)
- 56.9
- Beta (1Y)
- 0.13
- Revenue Growth
- -2.49%
- EPS Growth
- -82.69%
- Country
- Japan
- Employees
- 591
- Sector
- General
- Sector Strength
- 55
- Industry
- Business Equipment & Supplies
LIHIT LAB., INC. Business Overview & Revenue Model
Company Description
Lihit Lab., Inc., founded in Osaka, Japan, in 1938, manufactures and distributes a comprehensive range of office supplies both domestically and internationally. Their extensive product portfolio includes an array of filing and organizational solution...
How the Company Makes Money
LIHIT LAB. generates revenue primarily from the sale of stationery and office-supply products. Its core monetization model is product-based: it designs, manufactures and/or procures items such as file/folder systems and other desk and document organi...
LIHIT LAB., INC. Financial Statement Overview
Summary
Financials present a highly polarized profile. A fortress balance sheet with minimal debt is significantly offset by severe negative free cash flow, shrinking operating margins, and a poor return on equity.
Income Statement
45NeutralBalance Sheet
80PositiveCash Flow
30Negative| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.09B | 9.12B | 9.22B | 8.80B | 8.51B | 8.69B |
| Gross Profit | 3.04B | 3.00B | 2.88B | 2.52B | 2.50B | 2.90B |
| EBITDA | 368.57M | 306.06M | 822.07M | 174.54M | 261.38M | 725.53M |
| Net Income | 69.51M | 67.07M | 411.57M | -93.73M | -24.41M | 262.51M |
Balance Sheet | ||||||
| Total Assets | 13.68B | 13.52B | 13.43B | 13.12B | 13.03B | 13.62B |
| Cash, Cash Equivalents and Short-Term Investments | 1.43B | 728.51M | 2.33B | 1.24B | 1.08B | 2.26B |
| Total Debt | 226.00M | 282.00M | 437.50M | 751.50M | 445.00M | 698.00M |
| Total Liabilities | 2.46B | 2.54B | 2.79B | 2.88B | 2.81B | 3.51B |
| Stockholders Equity | 11.23B | 10.98B | 10.64B | 10.24B | 10.22B | 10.11B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -1.36B | 17.92M | -196.64M | -825.63M | 608.64M |
| Operating Cash Flow | 0 | 47.73M | 290.49M | 663.33M | -745.70M | 720.74M |
| Investing Cash Flow | 0 | -1.40B | 1.18B | -726.91M | -112.96M | -127.15M |
| Financing Cash Flow | 0 | -241.69M | -400.05M | 220.14M | -339.35M | -139.16M |
LIHIT LAB., INC. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7975, the sentiment is Positive. The current price of 1162.00 is above the 20-day moving average (MA) of 1153.80, above the 50-day MA of 1161.30, and above the 200-day MA of 1159.27, indicating a bullish trend. The MACD of -1.89 indicates Negative momentum. The RSI at 53.60 is Neutral, neither overbought nor oversold. The STOCH value of 93.45 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7975.
LIHIT LAB., INC. Peers Comparison
Overall Rating
JP:797676Outperform
JP:421875Outperform
JP:784674Outperform
JP:796266Neutral
JP:798464Neutral
JP:797546Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 76Outperform | JPY 186.74B | 22.75 | ― | 1.51% | 6.19% | 14.63% | |
| 75Outperform | JPY 40.59B | 19.58 | ― | 2.04% | 3.32% | 12.97% | |
| 74Outperform | JPY 261.27B | 14.72 | ― | 1.89% | 9.15% | 25.09% | |
| 66Neutral | JPY 20.56B | 15.99 | ― | 2.08% | 1.71% | 268.54% | |
| 64Neutral | JPY 374.00B | 16.55 | 9.06% | 2.90% | 9.10% | 8.80% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 46Neutral | JPY 3.94B | 56.86 | ― | 2.15% | -2.49% | -82.69% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:7975 | LIHIT LAB., INC. | 1162.00 | -49.10 | -4.05% | |
| JP:7984 | Kokuyo Co | 871.60 | -5.63 | -0.64% | |
| JP:4218 | Nichiban Co., Ltd. | 1959.00 | 39.71 | 2.07% | |
| JP:7846 | Pilot Corporation | 2171.00 | 642.72 | 42.06% | |
| JP:7962 | King Jim Co., Ltd. | 722.00 | -95.01 | -11.63% | |
| JP:7976 | Mitsubishi Pencil Company, Limited | 3605.00 | 1563.49 | 76.59% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 07, 2026
